TP53 and colorectal neuroendocrine tumor: These authors demonstrated that colorectal NECs presented a significantly higher tumor mutation burden (TMB) (5.16 versus 1.43) and a higher somatic mutation rate of TP53 (65.5% versus 6.8%) than colorectal NETs.